¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"collisionless plasma model"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
plasma component transfusion
Ç÷À强ºÐ¼öÇ÷
plasma cross matching
Ç÷Àå±³Â÷½ÃÇè
plasma exchange
Ç÷À屳ȯ(¼ú)
plasma expander
Ç÷ÀåÁõ·®Á¦
plasma hemoglobin
Ç÷ÀåÇ÷»ö¼Ò
plasma iron
Ç÷Àåö
plasma iron disappearance rate
Ç÷Àåö¼Ò½Ç·ü
plasma iron turnover rate
Ç÷Àåö±³Ã¼À²
plasma membrane
ÇüÁú¸·
plasma pepsinogen
Ç÷ÀåÆé½Ã³ë°Õ
plasma substitute
Ç÷Àå´ëüÁ¦
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
plasma volume expander
Ç÷ÀåÁõ·®Á¦
pooled blood plasma
È¥ÇÕÇ÷Àå
seminal plasma
Á¤¾×Àå¾×
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
plasma cell mastitis
ÇüÁú¼¼Æ÷À¯¹æ¿°
plasma cell myeloma
ÇüÁú¼¼Æ÷°ñ¼öÁ¾
plasma cross matching
(¢¡cross matching) Ç÷Àå±³Â÷½ÃÇè
plasma
Ç÷Àå, ¿øÇüÁú, ¼¼Æ÷Áú
plasma pepsinogen
Ç÷ÀåÆé½Ã³ë°Õ
plasma substitute
Ç÷Àå´ëÄ¡Á¦
plasma component transfusion
Ç÷À强ºÐ¼öÇ÷
plasma iron pool
Ç÷ÀåöÀúÀå°í
plasma iron disappearance rate
Ç÷Àåö¼Ò½Ç·ü
plasma iron turnover rate
Ç÷Àåö±³Ã¼À²
pooled blood plasma
È¥ÁÖÇ÷Àå
seminal plasma
Á¤¾×Àå¾×
true plasma
¼øÇ÷Àå
stable plasma protein solution
¾ÈÁ¤Ç÷Àå´Ü¹é¿ë¾×
absolute risk model
Àý´ëÀ§Çè¸ðÇü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
plasma
Ç÷Àå(úìíì), ÇöóÁ.
plasma
Ç÷Àå
plasma analysis
Ç÷ÀåºÐ¼®
plasma cell
ÇüÁú(û¡òõ)¼¼Æ÷
plasma cell
ÇüÁú¼¼Æ÷(û¡òõá¬øà).
plasma cell
ÇüÁú¼¼Æ÷
plasma cell
ÇüÁú¼¼Æ÷
plasma cell dyscrasia
ÇüÁú¼¼Æ÷ÀÌÈ¥ÈÁõ
plasma cell dyscrasia
ÇüÁú¼¼Æ÷Áúȯ(û¡òõá¬øàòðü´), ÇüÁú¼¼Æ÷Àå¾Ö(¡î¡äô), ÇüÁú¼¼Æ÷ÀÌÈ¥ÈÁõ(¡ì¶ûèûúñø)
plasma cell gingivostomatitis
ÇüÁú¼¼Æ÷ Ä¡Àº ±¸³»¿°
plasma cell leukemia
ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´
plasma cell leukemia
ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´(û¡òõá¬øààõ ÛÜúìÜ»)
plasma cell leukemia
ÇüÁú¼¼Æ÷ ¹éÇ÷º´
plasma cell mastitis
ÇüÁú¼¼Æ÷¼ºÀ¯¹æ¿°(û¡òõá¬øààõêáÛ®æú)
plasma cell myeloma
ÇüÁú¼¼Æ÷ °ñ¼öÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
homeostatic model
Ç×»ó¼º ¸ðÇü(Ù¼úþ)<Ç¥ÁØÇü>
in-the-ear model
±Í¼ÓÇü(º¸Ã»±â)
linear quadratic model
¼±Çü¹æÇü¸ðµ¨, ¼±ÇüÀÌÂ÷ÇÔ¼ö¸ðµ¨, LQ¸ðµ¨
model population
¸ðÇüÀα¸(ËÎÌ´ËöË´).
model psychosis
model trimmer
¸ðÇüÃÊÇÕ±â(¡ÞûùêѦ).
multitarget model
´ÙÇ¥Àû¸ðµ¨
multitarget multihit model
´ÙÇ¥Àû´ÙÀûÁß
multitarget single hit model
´ÙÇ¥Àû´ÜÀÏÀûÁß
nuclear model
(¿øÀÚ)ÇÙ¸ðÇü(ê«íú·Ù¼úþ).
organic model
À¯±â¸ðÇü(¡Ù¼úþ).
plaster model
±é½º Çü(¡úþ), ¼®°í ¸ðÇü.
psychodynamic experiential model
Á¤½Å¿ªµ¿Àû °æÇè¸ðµ¨
reserve model
¿¹ºñ¸ðÇü(çãÝáÙ¼úþ).
role model
¿ªÇÒÇ¥º»Çü(Ëç̰̰ËÓÌ´).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½